TY - JOUR T1 - Predicting Self-harm Incidents Following Inpatient Visits using Disease Comorbidity Network JF - medRxiv DO - 10.1101/2020.02.03.20019331 SP - 2020.02.03.20019331 AU - Zhongzhi Xu AU - Qingpeng Zhang AU - Paul Siu Fai Yip Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/04/2020.02.03.20019331.abstract N2 - Self-harm is serious but preventable, particularly if the risk can be identified early. But the early detection of self-harm individuals is so far not satisfied. This study aims to develop and test a comorbidity network-enhanced deep learning framework to improve the prediction of individual self-harm within 12 months after hospital discharge. Between January 1, 2007, and December 31, 2010, we obtained 2,323 patients with self-harm clinical record from 1,764,094 inpatients across 44 public hospitals in Hong Kong and 46,460 randomly sampled population controls from those same hospitals. Eighty percent (80%) of the study sample was randomly selected for model training, and the remaining 20% was set aside for model testing. The proposed comorbidity network-enhanced model was compared with a baseline deep learning model for self-harm prediction. The C-statistic, precision and sensitivity were used to evaluate the prediction accuracy of the proposed model and the baseline model. Experiments demonstrated that the proposed comorbidity network-enhanced model outperformed baseline model in identifying patients who would self-harm within 12 months (C-statistic of proposed model 0.89). The precision was 0.54 for positive cases and 0.98 for negative cases, whilst the sensitivity was 0.72 for positive cases and 0.96 for negative cases. Results indicated that it is critical to consider the general disease comorbidity patterns in self-harm screening and prevention programs. The model also extracted the most predictive diagnoses, and pairs of comorbid diagnoses which provide medical professionals with an effective screening strategy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded in part by the National Natural Science Foundation of China (NSFC) Grant Nos. 71972164 and 71672163, in part by the Health and Medical Research Fund Grant (HMRF) No. 16171991, in part by the Li Ka Shing Foundation and in part by The Theme-Based Research Scheme of the Research Grants Council of Hong Kong Grant No. T32-102/14N.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is provided by the Hospital Authority of Hong Kong the ethical approval UW11-495. The data can not be made available to others according to the Hospital Authority and the ethical approval. ER -